Australia's most trusted source of pharma news
Thursday, 20 September 2018
Lost Your Access?
ACCC ticks generics merger
Green light for Apotex/Arrow build potential market leader.
Speedy blood drug targets NBA
Roche's Hemlibra now looking for fast reimbursement.
Wilson would pilot NMP review
But not while still in PBAC chair.
Pharma tax claims flawed: ATO
Aust & NZ tax authorities reject anti-pharma Oxfam report.
Sydney pharma scores TGA win
Biocelect beats GSK in getting malaria pill to market.
Swan song for Sanofi
Praise and criticism from former Treasurer.
CSL reveals boss's pay
Take-home marginally lower than last year but still in millions.
Hunt gives Roche a boost
Announces $48m in PBS listings for October.
Sanofi announces restructure
Creating new business units from old.
Hurricane hits pharma plants
Pfizer, Novartis, MSD, Novo suspend manufacture.
Meds in need of rebrand
As important as food and water says MA chair.
MA value report in doubt
Future of long-awaited independent investigation uncertain.
Pharmacos ranked for diversity
CSL returns to top 100 with 10 other top companies.
Health schedules reform forums
Stakeholders to be informed on PBS streamlining.
It really is about trust
MA appears to be adopting the ostrich approach to trust deficit.
New psoriasis drug ticked
Already recommended by PBAC.
Asthma drug sped up
Amgen, AZ receive FDA boost after study readout.
Events & Conferences
© 2003 - 2018 Lush Media
Pharma in Focus
Jolly Good Design